PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · J Lab Physicians 2012; 4(02): 074-077
DOI: 10.4103/0974-2727.105585
Original Article

Antibiogram of Salmonella Isolates from Blood with an Emphasis on Nalidixic Acid and Chloramphenicol Susceptibility in a Tertiary Care Hospital in Coastal Karnataka: A Prospective Study

Autor*innen

  • Anup Kumar Shetty

    Department of Microbiology, Father Muller Medical College, Mangalore, Karnataka State, India

  • Ichlampady Nagaraj Shetty

    Department of Medicine, A.J. Institute of Medical Sciences, Kankanady, Mangalore, Karnataka State, India

  • Zevita Venisha Furtado

    Department of Microbiology, Father Muller Medical College, Mangalore, Karnataka State, India

  • Beena Antony

    Department of Microbiology, Father Muller Medical College, Mangalore, Karnataka State, India

  • Rekha Boloor

    Department of Microbiology, Father Muller Medical College, Mangalore, Karnataka State, India

Source of Support: Nil.
Weitere Informationen
Auch verfügbar auf
 als PDF herunterladen Lizenzen und Reprints

ABSTRACT

Background: Enteric fever is caused by the serotypes Salmonella Typhi, Salmonella Paratyphi A, Salmonella Paratyphi B and Salmonella Paratyphi C. After emergence of multidrug resistant Salmonellae Ciprofloxacin, a fluorquinolone antibiotic was the first-line therapy. Treatment failure was observed with Ciprofloxacin soon and such strains showed in-vitro resistance to Nalidixic acid. Recent reports suggest re-emergence of Chloramphenicol sensitive strains and increasing Nalidixic acid resistance. This study is aimed at detecting the current trend in the antibiogram of Salmonella isolates from blood culture in coastal Karnataka, with an emphasis on antibiotic susceptibility of Nalidixic acid and Chloramphenicol and evaluate, if there is a need to modify the strategies in the antibiotic therapy for enteric fever.

Materials and Methods: Blood samples received for culture in the laboratory between June 2009 and August 2011 was cultured in Brain Heart infusion broth, bile broth or in a commercial BACTEC culture media. The growth from blood cultures were processed for identification and antibiotic susceptibility as per standard methods. Antibiotic susceptibility for Ampicillin, Trimethoprim-sulphamethoxazole, Chloramphenicol, Ciprofloxacin, Ceftriaxone and Nalidixic acid were noted.

Results: Out of 9053 blood culture specimens received, Salmonella was isolated from 103 specimens. There were 85 Salmonella Typhi isolates, 16 Salmonella Paratyphi A and two Salmonella Paratyphi B. Salmonella Typhi and Salmonella Paratyphi A showed the highest resistance to Nalidixic acid. Salmonella Typhi showed highest susceptibility to Ceftriaxone and Salmonella Paratyphi A to trimethoprim-sulphamethoxazole and Chloramphenicol. Two isolates were multidrug resistant. One Salmonella Paratyphi A was resistant to Ceftriaxone.

Conclusion: Routine screening of Nalidixic acid susceptibility is practical to predict fluorquinolone resistance in Salmonella and preventing therapeutic failure while treating with it. It is worthwhile to consider replacing fluorquinolones with Chloramphenicol or Ceftriaxone as the first line of therapy for enteric fever. Periodic analysis of Salmonella antibiogram should be done to formulate the best possible treatment strategies.

Keywords

Ceftriaxone - Chloramphenicol - Nalidixic acid - resistance - Salmonella


Publikationsverlauf

Artikel online veröffentlicht:
09. Mai 2020

© 2012.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • REFERENCES

  • 1 Drug-resistant Salmonella (WHO website). April 2005. Available from: http://www.who.int/mediacentre/factsheets/fs139/en/. [Last Accessed on 2012 Mar 04].
  • 2 Harish BN, Menezes GA. Antimicrobial resistance in typhoidal salmonellae. Indian J Med Microbiol 2011;29:223-9.
  • 3 Ananthnarayan R, Paniker KJ. Enterobacteriaceae III: Salmonella. In: Ananthnarayan and Paniker′s Textbook of Microbiology. 8th ed. Hyderabad: Universities Press (India) Private Limited; 2009. p. 288-301.
  • 4 Kumar Y, Sharma A, Mani KR. Re-emergence of susceptibility to conventionally used drugs among strains of Salmonella of Salmonella Typhi in central west India. J Infect Dev Ctries 2011;5:227-30.
  • 5 Capoor MR, Nair D. Quinolone and cephalosporin resistance in enteric fever. J Glob Infect Dis 2010;2:258-62.
  • 6 Stevenson JE, Gay K, Barrett TJ, Medalla F, Chiller TM, Angulo FJ. Increase in Nalidixic acid resistance among Non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003. Antimicrob Agents Chemother 2007;51:195-7.
  • 7 CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Infromational Supplement. CLSI Document M100-S19. Wayne PA: Clinical and Laboratory Standards Institute; 2009.
  • 8 Gorman R, Adley CC. Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluorquinolones in the mid-west region of the republic of Ireland. J Antimicrob Chemother 2003;51:1047-9.
  • 9 Kumar Y, Sharma A, Mani KR. High level of resistance to Nalidixic acid in Salmonella enteric serovar Typhi in Central India. J infect Dev Ctries 2009;3:467-9.
  • 10 Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiogram of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006;24:45-8.
  • 11 Koneman EW, Allen SD, Janda WM, Schreckberger PC, Winn CW Jr. The Enterobacteriaceae. In: Colour Atlas and textbook of diagnostic Microbiology. 5th ed. PA: LippinTMP-SMZt Williams and Wilkins Company; 1997. p. 171-252.
  • 12 Miles RS, Amyes SG. Laboratory Control of Antimicrobial Therapy. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology. 14th ed. NY: Churchill Livingstone; 1996. p. 151-78
  • 13 Barrow GI, Feltham RK, editors. Characters of Gram negative bacteria. In: Cowan and Steel›s Manual for Identification of Medical Bacteria. 3rd ed. Cambridge: Cambridge University Press; 2003. p. 94-164.
  • 14 Tankhiwale SS, Agrawal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enteric serotype Paratyphi A in patients with enteric fever. Indian J Med Res 2003;117:10-12.
  • 15 Palit A, Ghosh S, Dutta S, Sur D, Bhattacharya MK, Bhattacharya SK. Increasing prevalence of Salmonella enterica serotype Paratyphi-A in patients with enteric fever in a periurban slum setting of Kolkata India. Int J Environ Health Res 2006;16:455-9.
  • 16 Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enteric Serotype Typhi in Eastern Nepal. J Health Popul Nutr 2007;25:82-7.
  • 17 Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J infect Dev Ctries 2010; 4:393-6.
  • 18 Chitnis V, Chitnis D, Verma S, Hemvani N. Multidrug resistant Salmonella typhi in India. The Lancet 1999; 354:514-5.
  • 19 Angulo FJ, Nargund VN, Chiller TC. Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J Vet Med B Infect Dis Vet Public Health 2004;51:374-9.
  • 20 Mukhopadhyay C, Rao PS, Shetty AK, Vidyasagar S, Varma M. Haemorrhagic pleural effusion in an HIV patient with Salmonella Typhimurium. J Clin Diagn Res 2007;4:299-302.